Journal
NATURE COMMUNICATIONS
Volume 10, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-019-12101-z
Keywords
-
Categories
Funding
- European Research Council (ERC) [616434]
- Spanish Ministry of Economy and Competitiveness [BFU2014-55054-P, BFU2017-86970-P, BFU2017-89488-P]
- AXA Research Fund
- Bettencourt Schueller Foundation
- Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [SGR-831]
- European Research Council [RIBOMYLOME_309545]
- Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa'
- EMBL Partnership
- CERCA Program/Generalitat de Catalunya
Ask authors/readers for more resources
Insoluble protein aggregates are the hallmarks of many neurodegenerative diseases. For example, aggregates of TDP-43 occur in nearly all cases of amyotrophic lateral sclerosis (ALS). However, whether aggregates cause cellular toxicity is still not clear, even in simpler cellular systems. We reasoned that deep mutagenesis might be a powerful approach to disentangle the relationship between aggregation and toxicity. We generated >50,000 mutations in the prion-like domain (PRD) of TDP-43 and quantified their toxicity in yeast cells. Surprisingly, mutations that increase hydrophobicity and aggregation strongly decrease toxicity. In contrast, toxic variants promote the formation of dynamic liquid-like condensates. Mutations have their strongest effects in a hotspot that genetic interactions reveal to be structured in vivo, illustrating how mutagenesis can probe the in vivo structures of unstructured proteins. Our results show that aggregation of TDP-43 is not harmful but protects cells, most likely by titrating the protein away from a toxic liquid-like phase.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available